Past Podcast Episodes

The new year brings with it several significant benefits for many people affected by MS. We're reviewing how the nearly 400,000 people with MS who rely on Medicare for their health insurance will save thousands of dollars, how people with MS who currently have medical debt will see a big improvement on their credit report, and how people who fly with their mobility device will see major improvements in how the airlines treat them.

We're also talking with Craig Bianco about his experience as a member of the Care Partner Advisory Board creating the MS Care Partner Connection web portal.

And we'll tell you about the Phase 1 clinical trial for the Epstein-Barr Virus vaccine that's getting underway.

We have a lot to talk about! Are you ready for RealTalk MS??!

This Week: Where to get support if you have MS and you're a victim of the Southern California fires   :22

Here's where and how 2025 is delivering new and improved benefits for many people with MS  2:06

Department of Transportation adopts new rules to improve flying for people with disabilities  10:26

Modex Therapeutics, in collaboration with Merck, announces Phase 1 clinical trial for Epstein-Barr Virus vaccine  14:03

Craig Bianco talks about his experience as a member of the Care Partner Advisory Board creating the MS Care Partner Connection web portal     17:26

Share this episode  29:12

Have you downloaded the free RealTalk MS app?  29:32

SHARE THIS EPISODE OF REALTALK MS

Just copy this link & paste it into your text or email: https://realtalkms.com/385

ADD YOUR VOICE TO THE CONVERSATION

I've always thought about the RealTalk MS podcast as a conversation. And this is your opportunity to join the conversation by sharing your feedback, questions, and suggestions for topics that we can discuss in future podcast episodes. Please shoot me an email or call the RealTalk MS Listener Hotline and share your thoughts!

Email: jon@realtalkms.com
Phone: (310) 526-2283

And don't forget to join us in the RealTalk MS Facebook group!

LINKS

If your podcast app doesn't allow you to click on these links, you'll find them in the show notes in the RealTalk MS app or at www.RealTalkMS.com

RealTalk MS on YouTube
https://www.youtube.com/@RealTalkMS

MS Care Partner Connection
https://mscarepartnerconnection.com

Find Out How You Can Become an MS Activist
https://nationalmssociety.org/advocacy

RealTalk MS Episode 302: De-Stressing Air Travel if You're Living with MS with Dr. Scott Crawford
https://realtalkms.com/302

Join the RealTalk MS Facebook Group
https://facebook.com/groups/realtalkms

Download the RealTalk MS App for iOS Devices
https://itunes.apple.com/us/app/realtalk-ms/id1436917200

Download the RealTalk MS App for Android Devices
https://play.google.com/store/apps/details?id=tv.wizzard.android.realtalk

Give RealTalk MS a rating and review
http://www.realtalkms.com/review

Follow RealTalk MS on Twitter, @RealTalkMS_jon, and subscribe to our newsletter at our website, RealTalkMS.com.

RealTalk MS Episode 385
Guest: Craig Bianco

 

There are genetic risks associated with MS, there are demographic risks of experiencing a more severe disease course, and there are also behavioral and lifestyle risks that will increase the chance that someone will be diagnosed with MS. Joining me today to discuss behavioral and lifestyle MS risk factors and how they can be mitigated are Doctor Jared Bruce and Dr. Amanda Bruce.

Dr. Jared Bruce is a neuropsychologist and the director of psychiatric research at the University of Missouri-Kansas City School of Medicine. Dr. Amanda Bruce is a clinical psychologist and an assistant professor in the Department of Behavioral Pediatrics at the University of Kansas Medical Center.

We're also reviewing the details of the Inflation Reduction Act, which means, beginning in 2025, significantly lower out-of-pocket costs for prescription medications for the quarter-million people with MS who are on Medicare.

We'll tell you about study results for a novel drug that was effective in remyelination and restoring lost function to mice with the mouse model of MS.

We'll share the details of a study that shows how specific comorbidities affect specific MS outcomes.

We'll review results of a study that shows men with MS who start a high-efficacy disease-modifying therapy experience fewer relapses.

And we'll tell you how an artificial intelligence chatbot soundly beat human experts in predicting the results of neuroscience studies.

We have a lot to talk about! Are you ready for RealTalk MS??!

This Week: Behavioral and Lifestyle risk factors for MS (and how to mitigate them)   :22

It's 2025, and that means significant out-of-pocket savings on prescription medications for people with MS on Medicare  1:20

Novel drug shows effectiveness in remyelination and restoring function in mouse model of MS  3:26

Study shows how specific comorbidities affect specific MS outcomes  5:17

Study shows men on high-efficacy disease-modifying therapies experience fewer MS relapses  8:46

Study shows AI beats human experts in predicting results of neuroscience studies  12:22

Dr. Jared Bruce and Dr. Amanda Bruce discuss behavioral and lifestyle MS risk factors   16:43

Share this episode  32:13

Have you downloaded the free RealTalk MS app?  32:33

SHARE THIS EPISODE OF REALTALK MS

Just copy this link & paste it into your text or email: https://realtalkms.com/384

ADD YOUR VOICE TO THE CONVERSATION

I've always thought about the RealTalk MS podcast as a conversation. And this is your opportunity to join the conversation by sharing your feedback, questions, and suggestions for topics that we can discuss in future podcast episodes. Please shoot me an email or call the RealTalk MS Listener Hotline and share your thoughts!

Email: jon@realtalkms.com
Phone: (310) 526-2283

And don't forget to join us in the RealTalk MS Facebook group!

LINKS

If your podcast app doesn't allow you to click on these links, you'll find them in the show notes in the RealTalk MS app or at www.RealTalkMS.com

RealTalk MS on YouTube
https://www.youtube.com/@RealTalkMS

STUDY: Selective Retinoid X Receptor Agonism Promotes Functional Recovery and Myelin Repair in Experimental Autoimmune Encephalomyelitis
https://actaneurocomms.biomedcentral.com/articles/10.1186/s40478-024-01904-x

STUDY: Comorbidities and Their Association with Outcomes In the Multiple Sclerosis Population: A Rapid Review
https://msard-journal.com/article/S2211-0348(24)00519-4/fulltext

STUDY EXPLAINED (Plain English): Comorbidities and Their Association with Outcomes In the Multiple Sclerosis Population: A Rapid Review
https://tremlettsmsresearchexplained.wordpress.com/2024/10/29/comorbidities-and-their-association-with-outcomes-in-the-multiple-sclerosis-population-a-rapid-review-explained

STUDY: Comparative Effectiveness of High-Efficacy and Moderate-Efficacy Disease-Modifying Agents in Reducing the Annualized Relapse Rates Among Multiple Sclerosis Patients in the United States
https://sciencedirect.com/science/article/abs/pii/S0091743524003359

STUDY: Large Language Models Surpass Human Experts in Predicting Neuroscience Results
https://nature.com/articles/s41562-024-02046-9

Join the RealTalk MS Facebook Group
https://facebook.com/groups/realtalkms

Download the RealTalk MS App for iOS Devices
https://itunes.apple.com/us/app/realtalk-ms/id1436917200

Download the RealTalk MS App for Android Devices
https://play.google.com/store/apps/details?id=tv.wizzard.android.realtalk

Give RealTalk MS a rating and review
http://www.realtalkms.com/review

Follow RealTalk MS on Twitter, @RealTalkMS_jon, and subscribe to our newsletter at our website, RealTalkMS.com.

RealTalk MS Episode 384
Guests: Dr. Jared Bruce and Dr. Amanda Bruce